The Impact of Prostate-Specific Antigen and Gleason Scores on Cardiovascular Death in Prostate Cancer Patients after Radiotherapy or Chemotherapy: A Population-Based Study [PDF]
Reviews in Cardiovascular MedicineBackground: Tumor characteristics are associated with the risk of cardiovascular death (CVD) in cancer patients. However, the influence of tumor characteristics on CVD risk among prostate cancer (PC) patients who have received ...
Huijuan He +6 more
doaj +2 more sources
Uric acid to albumin ratio is a novel predictive marker for all-cause and cardiovascular death in diabetic patients: a prospective cohort study [PDF]
Frontiers in EndocrinologyBackgroundDiabetes is one of the leading causes of death with an increasing prevalence worldwide. Diabetes-related premature mortality is largely preventable and reversible if identified and managed early.
Shengnan Chen +7 more
doaj +2 more sources
Trends and Disparities in Cardiovascular Death in Sarcoidosis: A Population‐Based Retrospective Study in the United States From 1999 to 2020 [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Despite significant cardiac involvement in sarcoidosis, real‐world data on death due to cardiovascular disease among patients with sarcoidosis is not well established.
Min Choon Tan +7 more
doaj +2 more sources
Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground The prognostic implication of mildly reduced ejection fraction (mrEF) after acute myocardial infarction has not been clearly demonstrated.
Hwajung Kim +10 more
doaj +2 more sources
Resuscitation Plus, 2023 Background: While the short-term prognosis of cardiac arrest patients - nearly 250,000 new cases per year in Europe - has been extensively studied, less is known regarding the mid and long-term outcome of survivors.
F. Dumas +17 more
doaj +1 more source
Cells, 2020 The vitamin K-dependent factors protein S (PROS1) and growth-arrest-specific gene 6 (GAS6) and their tyrosine kinase receptors TYRO3, AXL, and MERTK, the TAM subfamily of receptor tyrosine kinases (RTK), are key regulators of inflammation and vascular ...
Anna Tutusaus +5 more
doaj +1 more source
Scientific Reports, 2023 Hypertrophic cardiomyopathy (HCM) is a genetically heterogenous condition with about half of cases remaining genetically elusive or non-genetic in origin.
Ramin Garmany +10 more
doaj +1 more source
Biomedicines, 2021 Background: Growth arrest-specific factor 6 (GAS6) and the Tyro3, AXL, and MERTK (TAM) receptors counterbalance pro-inflammatory responses. AXL is a candidate receptor for SARS-CoV-2, particularly in the respiratory system, and the GAS6/AXL axis is ...
Albert Morales +11 more
doaj +1 more source
Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis
Stem Cells International, 2022 Hypoxia preconditioning enhances the paracrine abilities of mesenchymal stem cells (MSCs) for vascular regeneration and tissue healing. Implantation of hypoxia-induced mesenchymal stem cells (hi-MSCs) may further improve limb perfusion in a murine model ...
Farina Mohamad Yusoff +8 more
doaj +1 more source
Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
ESC Heart Failure, 2023 Aims Data on the clinical course of hypertrophic cardiomyopathy (HCM) are mainly derived from tertiary HCM centre studies, and knowledge of clinical outcomes of patients leaving specialty care and returning to local physicians is limited due to gaps ...
Ramin Garmany +4 more
doaj +1 more source